Vitamin D deficiency in non-alcoholic fatty liver disease: The chicken or the egg?

Clinical Nutrition

Volumn 36, Issue 1, 2017, Pages 191-197

  Lee, Seung Min ^a   Jun, Dae Won ^b   Cho, Yong Kyun ^c   Jang, Ki Seol ^b  

^a Sungshin Women's University   (South Korea)

^b Hanyang University   (South Korea)

^c School of Medicine   (South Korea)

Author keywords

Non alcoholic fatty liver disease; Sunlight exposure; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; AMINOTRANSFERASE; LIVER ENZYME; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; VITAMIN D;

ABDOMINAL OBESITY; ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY WEIGHT; CALORIC RESTRICTION; CONTROLLED STUDY; DIETITIAN; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; NUTRITION EDUCATION; PHYSICAL ACTIVITY; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION; WEIGHT LOSS PROGRAM; WEIGHT REDUCTION; BLOOD; BODY WEIGHT LOSS; COMPLICATION; DIETARY SUPPLEMENT; EXERCISE; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL (TOPIC); ULTRAVIOLET RADIATION;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BLOOD GLUCOSE; CALORIC RESTRICTION; CHOLESTEROL; DIETARY SUPPLEMENTS; EXERCISE; FEMALE; HUMANS; MALE; METABOLIC SYNDROME; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY, ABDOMINAL; PREVALENCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; ULTRAVIOLET RAYS; VITAMIN D; VITAMIN D DEFICIENCY; WEIGHT LOSS; WEIGHT REDUCTION PROGRAMS;

EID: 84947996830     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2015.10.017     Document Type: Article

References (27)

1. Ford, E.S., Ajani, U.A., McGuire, L.C., Liu, S., Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 28 (2005), 1228–1230.
2. Ford, E.S., Zhao, G., Li, C., Pearson, W.S., Serum concentrations of vitamin D and parathyroid hormone and prevalent metabolic syndrome among adults in the United States. J Diabetes 1 (2009), 296–303.
3. Lu, L., Yu, Z., Pan, A., Hu, F.B., Franco, O.H., Li, H., et-al, Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care 32 (2009), 1278–1283.
4. Holick, M.F., Siris, E.S., Binkley, N., Beard, M.K., Khan, A., Katzer, J.T., et-al, Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 90 (2005), 3215–3224.
5. Lips, P., Hosking, D., Lippuner, K., Norquist, J.M., Wehren, L., Maalouf, G., et-al, The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation. J Intern Med 260 (2006), 245–254.
6. Orwoll, E., Nielson, C.M., Marshall, L.M., Lambert, L., Holton, K.F., Hoffman, A.R., et-al, Osteoporotic Fractures in Men (MrOS) Study Group. Vitamin D deficiency in older men. J Clin Endocrinol Metab 94 (2009), 1214–1222.
7. Seo, J.A., Eun, C.R., Cho, H., Lee, S.K., Yoo, H.J., Kim, S.G., et-al, Low vitamin D status is associated with nonalcoholic fatty liver disease independent of visceral obesity in Korean adults. PLoS ONE, 8, 2013, e75197.
8. Jablonski, K.L., Jovanovich, A., Holmen, J., Targher, G., McFann, K., Kendrick, J., et-al, Low 25-hydroxyvitamin D level is independently associated with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 23 (2013), 792–798.
9. Dasarathy, J., Periyalwar, P., Allampati, S., Bhinder, V., Hawkins, C., Brandt, P., et-al, Hypovitaminosis D is associated with increased whole body fat mass and greater severity of non-alcoholic fatty liver disease. Liver Int, 2013.
10. Hashemi Kani, A., Alavian, S.M., Esmaillzadeh, A., Adibi, P., Azadbakht, L., Dietary quality indices and biochemical parameters among patients with non alcoholic fatty liver disease (NAFLD). Hepat Mon, 13, 2013, e10943.
11. Eliades, M., Spyrou, E., Agrawal, N., Lazo, M., Brancati, F.L., Potter, J.J., et-al, Meta-analysis: vitamin D and non-alcoholic fatty liver disease. Alimentary Pharmacol Therapeut 38 (2013), 246–254.
12. Han, J.M., Jo, A.N., Lee, S.M., Bae, H.S., Jun, D.W., Cho, Y.K., et-al, Associations between intakes of individual nutrients or whole food groups and non-alcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol 29 (2014), 1265–1272.
13. Alberti, K.G., Zimmet, P., Shaw, J., The metabolic syndrome – a new worldwide definition. Lancet 366 (2005), 1059–1062.
14. Global Atmosphere Watch, Summary of Korea global atmosphere watch 2011 report. 2012, Korea Meteorological Administration.
15. Abenavoli, L., Milic, N., Luigiano, C., Low 25-hydroxyvitamin D3 serum levels and non-alcoholic fatty liver disease. Minerva Medica, 105, 2014, 175.
16. Sharifi, N., Amani, R., Hajiani, E., Cheraghian, B., Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial. Endocrine 47 (2014), 70–80.
17. Drincic, A.T., Armas, L.A., Van Diest, E.E., Heaney, R.P., Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity 20 (2012), 1444–1448.
18. Pourshahidi, L.K., Vitamin D and obesity: current perspectives and future directions. Proc Nutr Soc 74 (2015), 115–124.
19. Lee, S.H., Park, S.J., Kim, K.M., Lee, D.J., Kim, W.J., Park, R.W., et-al, Effect of sunlight exposure on serum 25-hydroxy vitamin D concentration in women with vitamin D deficiency: using ambulatory lux meter and sunlight exposure questionnaire. Korean J Fam Med 33 (2012), 381–389.
20. Mason, C., Xiao, L., Imayama, I., Duggan, C., Wang, C.Y., Korde, L., et-al, Vitamin D3 supplementation during weight loss: a double-blind randomized controlled trial. Am J Clin Nutr 99 (2014), 1015–1025.
21. Mason, C., Xiao, L., Imayama, I., Duggan, C.R., Bain, C., Foster-Schubert, K.E., et-al, Effects of weight loss on serum vitamin D in postmenopausal women. Am J Clin Nutr 94 (2011), 95–103.
22. Kong, M., Zhu, L., Bai, L., Zhang, X., Chen, Y., Liu, S., et-al, Vitamin D deficiency promotes nonalcoholic steatohepatitis through impaired enterohepatic circulation in animal model. Am J Physiol Gastrointest Liver Physiol 307 (2014), G883–G893.
23. Bechmann, L.P., Hannivoort, R.A., Gerken, G., Hotamisligil, G.S., Trauner, M., Canbay, A., The interaction of hepatic lipid and glucose metabolism in liver diseases. J Hepatol 56 (2012), 952–964.
24. Manna, P., Jain, S.K., Vitamin D up-regulates glucose transporter 4 (GLUT4) translocation and glucose utilization mediated by cystathionine-gamma-lyase (CSE) activation and H2S formation in 3T3L1 adipocytes. J Biol Chem 287 (2012), 42324–42332.
25. Zoico, E., Franceschetti, G., Chirumbolo, S., Rossi, A.P., Mazzali, G., Rizzatti, V., et-al, Phenotypic shift of adipocytes by cholecalciferol and 1alpha,25 dihydroxycholecalciferol in relation to inflammatory status and calcium content. Endocrinology 155 (2014), 4178–4188.
26. Park, S.H., Kim, P.N., Kim, K.W., Lee, S.W., Yoon, S.E., Park, S.W., et-al, Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology 239 (2006), 105–112.
27. Georgoff, P., Thomasson, D., Louie, A., Fleischman, E., Dutcher, L., Mani, H., et-al, Hydrogen-1 MR spectroscopy for measurement and diagnosis of hepatic steatosis. Am J Roentgenol 199 (2012), 2–7.